Why Plastopil's Food Segment Broke in a Year of New Capacity and U.S. Expansion
Plastopil's food segment lost about 14% of revenue and roughly 76% of segment profit in 2025, even as the company expanded in the U.S. and pushed its recyclable-packaging story harder. The filings support a timing mismatch more than a strategic collapse: Europe and price pressure hit immediately, while the new platform still had not proved its margin power.
The main article argued that Plastopil's food segment is the real quality bottleneck in the group. This follow-up isolates a narrower question: did 2025 look weak because of temporary European softness, or did the added capacity, the U.S. push, and the recyclable-packaging story simply fail to turn into margin?
The filings point more clearly to a timing mismatch than to a collapse of the strategy. The old European food core entered 2025 with weaker demand, downward price pressure, and a commercial structure still built largely on orders rather than long-duration contracts. At the same time, the new layer, recyclable products, the PFAS-free transition, a local U.S. platform, and the Forem acquisition, are still presented mostly as capability build, customer approvals, and early commercialization. The old business therefore weakened before the new one was large enough to carry the numbers.
That matters because if this reading is right, 2025 is not proof that the advanced-packaging story does not work. It is proof that Plastopil still has not shown that the story already pays enough to offset Europe.
Where the segment actually broke
The food-segment numbers are too sharp to dismiss as ordinary ramp noise. Revenue fell to ILS 182.4 million in 2025 from ILS 213.1 million, while ordinary segment profit dropped to ILS 3.9 million from ILS 16.0 million. That means the segment margin fell from about 7.5% to roughly 2.1%.
Management itself points to the first explanation: the revenue decline stemmed mainly from weaker demand in Europe. That is not a side note. If Europe is the company's own first explanation, that is where the analysis has to start, not with the U.S. headline.
But weaker demand alone does not explain why the margin compressed so violently. To understand the depth of the reset, you have to look at the economic shape of the business. Food packaging is supposed to carry technology, quality, regulation, barrier properties, and specialized products. When a segment like that drops to a little above a 2% margin, the implication is not just lower volume. Pricing power or revenue quality also weakened.
Europe is the first explanation, but the sales model explains why it hit margin so fast
In its food-activity discussion, the company describes the European market as highly competitive, with ongoing downward price pressure. At the same time, it says customers in Western Europe are shifting toward lower-environmental-impact products, thinner structures, and compositions that enable recycling or incorporate recycled content. That is exactly the kind of market where innovation is needed just to stay relevant, while pricing becomes harder to defend.
The more important point is the channel structure. Most export sales are made through distributors. Most customer relationships are built on recurring orders rather than long-term framework contracts. Some distributors do not have exclusivity, and they also sell competing products. In other words, Plastopil has reach and service capability, but not necessarily the kind of locked-in customer structure that cushions a demand slowdown without giving up price.
Even the broad customer base does not mean the pressure is truly dispersed. The company says one customer with several sites in Europe and the U.S. accounted for about 13% of food-segment revenue and about 6% of group revenue. There is a framework agreement, but it mainly covers pricing, logistics, operations, and credit, while the purchases themselves are still made through ongoing orders. That is a structure that supports active commercial flow, but it is also a structure in which commercial pressure can pass through quickly to profit.
That is the core read of 2025. Europe did not just hurt volume. It hit a segment where a large part of export sales still runs through distributors, recurring orders, and customers that want both competitive pricing and a greener product offering. In that environment, innovation matters for staying in the game, but it does not automatically protect margin.
The U.S. and recyclable-packaging story still did not rescue 2025
This is where Plastopil's filings are more interesting than the headline. On the one hand, the product story is real. The presentation describes the Toplex and Multiform families as innovative high-barrier products that are recyclable in common PP or PE streams. The company also presents fully recyclable flexible food packaging and what it calls a leading set of recyclable lamination-film solutions. It also frames higher recyclable-film capacity and broader recycling capability as part of the growth story.
The company is not standing still in the U.S. either. The presentation describes a material expansion of commercial ties in the American market, the establishment of an independent unit with supplemental production capability and a central warehouse in Rhode Island, a local sales and marketing infrastructure, and the relocation of a sales manager to the U.S. site. On top of that, Forem was acquired in November 2025, and management explicitly frames the U.S. market as a strategic growth engine.
But when you try to connect all of that to the income line of the food segment, you hit the central limitation of 2025: the strategy is disclosed, but the monetization is barely quantified.
| Strategic layer | What is disclosed | What is still not disclosed, so success cannot yet be declared |
|---|---|---|
| Recyclable food products | Toplex and Multiform are presented as high-barrier recyclable solutions, and the company also presents fully recyclable food packaging | There is no separate disclosure for the revenue, margin, or price premium generated by these products inside the food segment |
| PFAS-free transition | The company notes an outright ban in the U.S. and an expected European rollout during 2026, while also saying it is in the middle of a PFAS-free transition and an accelerated product-approval process with customers | There is no quantification of the cost, pace, or economic contribution of that transition in 2025 |
| U.S. push | A local unit in Rhode Island was established, a local commercial infrastructure was built, and Forem was acquired | There is no split showing how much of U.S. sales belongs to food, and what margin that business generated |
| Forem acquisition | Forem added customers and packaging solutions in the U.S., Central America, and South America | November-December sales were only ILS 3 million, so it is too early to assign it enough weight to explain the 2025 reset |
The presentation adds two especially useful datapoints. First, total U.S. sales in 2025 amounted to ILS 69 million. Second, Forem contributed only ILS 3 million in November-December. Those numbers say something precise: the U.S. is no longer a side experiment, but Forem is still far too early to explain a 2025 food-margin recovery that did not happen.
The same logic applies to recyclable packaging. Plastopil is clearly presenting real products here, not empty slogans. But the company does not disclose how much revenue or margin those solutions generated inside the food segment. So it is not possible to argue that the strategy failed. It is only possible to say that in 2025 it still was not disclosed at a scale large enough to offset Europe.
This looks more like a monetization reset year than a full strategic failure
Once the evidence is ranked by weight, the picture is fairly clear.
The first explanation is Europe. That is the only factor the company directly identifies as the reason for the segment's revenue decline. The second explanation is a commercial structure that makes it hard to defend margin in a slowdown: distributors, recurring orders, one meaningful customer, and competition that is clearly not easing. The third explanation is timing: recyclable products, the local U.S. organization, Forem, and the PFAS-free transition all look like a real build-out layer, but not yet like a profit layer that can be measured cleanly.
What is less supported is the harsher claim that Plastopil has already failed to monetize the advanced-packaging story. To make that claim, the filings would need to show either that the advanced products are not selling, or that the U.S. and recyclable platform are already large and measurable inside the segment while the economics are still worsening. The 2025 materials do not yet provide that evidence.
Put differently, 2025 looks like a year in which the old commercial pressure was immediate, while the new strategic story was still too early. That does not excuse management. It does the opposite. If food is supposed to be Plastopil's quality segment, it now has to show quickly that the advanced products and the U.S. platform do more than widen the story. They have to repair the margin.
Bottom line
Plastopil's food segment did not break in 2025 because it lacked a story. It broke because the new story was still not embedded deeply enough in the segment's economics, while the older European base was already operating under weaker demand and heavier price pressure.
So the right read at this stage is not that the U.S. failed, and not that recyclable food packaging is an illusion. The right read is that Plastopil has already built a platform that should improve the quality of the food segment, but as of 2025 it still has not proved that the platform can command price, defend margin, and compensate for Europe.
The key test in the next set of results will be straightforward. If the food-segment margin recovers before any extreme jump in revenue, 2025 will look like a reset year in retrospect. If revenue stabilizes but margin stays close to 2%, that will be a much harder indication that Plastopil's innovation story is generating commercial relevance faster than it is generating profit.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.